BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 37422377)

  • 1. Burden of illness associated with Respiratory Syncytial Virus (RSV)-related hospitalizations among adults in Ontario, Canada: A retrospective population-based study.
    Mac S; Shi S; Millson B; Tehrani A; Eberg M; Myageri V; Langley JM; Simpson S
    Vaccine; 2023 Aug; 41(35):5141-5149. PubMed ID: 37422377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Health care costs of hospitalization of young children for respiratory syncytial virus infections: a population-based matched cohort study.
    Thampi N; Knight BD; Thavorn K; Webster RJ; Lanctot K; Hawken S; McNally JD
    CMAJ Open; 2021; 9(4):E948-E956. PubMed ID: 34667075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence of Hospitalization for Respiratory Syncytial Virus Infection amongst Children in Ontario, Canada: A Population-Based Study Using Validated Health Administrative Data.
    Pisesky A; Benchimol EI; Wong CA; Hui C; Crowe M; Belair MA; Pojsupap S; Karnauchow T; O'Hearn K; Yasseen AS; McNally JD
    PLoS One; 2016; 11(3):e0150416. PubMed ID: 26958849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors and medical resource utilization in US adults hospitalized with influenza or respiratory syncytial virus in the Hospitalized Acute Respiratory Tract Infection study.
    Hartnett J; Donga P; Ispas G; Vandendijck Y; Anderson D; House S; Suner S
    Influenza Other Respir Viruses; 2022 Sep; 16(5):906-915. PubMed ID: 35474419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimating the Incidence of First RSV Hospitalization in Children Born in Ontario, Canada.
    Buchan SA; Chung H; To T; Daneman N; Guttmann A; Kwong JC; Murti M; Aryal G; Campigotto A; Chakraborty P; Gubbay J; Karnauchow T; Katz K; McGeer AJ; Dayre McNally J; Mubareka S; Richardson D; Richardson SE; Smieja M; Zahariadis G; Deeks SL
    J Pediatric Infect Dis Soc; 2023 Jul; 12(7):421-430. PubMed ID: 37335754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Change in functional status associated with respiratory syncytial virus infection in hospitalized older adults.
    Branche AR; Saiman L; Walsh EE; Falsey AR; Jia H; Barrett A; Alba L; Phillips M; Finelli L
    Influenza Other Respir Viruses; 2022 Nov; 16(6):1151-1160. PubMed ID: 36069297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimating the burden of adult hospitalized RSV infection using local and state data - methodology.
    Balasubramani GK; Nowalk MP; Eng H; Zimmerman RK
    Hum Vaccin Immunother; 2022 Dec; 18(1):1958610. PubMed ID: 35271432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluating the Individual Healthcare Costs and Burden of Disease Associated with RSV Across Age Groups.
    Rafferty E; Paulden M; Buchan SA; Robinson JL; Bettinger JA; Kumar M; Svenson LW; MacDonald SE;
    Pharmacoeconomics; 2022 Jun; 40(6):633-645. PubMed ID: 35553028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Economic and disease burden of RSV-associated hospitalizations in young children in France, from 2010 through 2018.
    Demont C; Petrica N; Bardoulat I; Duret S; Watier L; Chosidow A; Lorrot M; Kieffer A; Lemaitre M
    BMC Infect Dis; 2021 Aug; 21(1):730. PubMed ID: 34340679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term Assessment of Healthcare Utilization 5 Years After Respiratory Syncytial Virus Infection in US Infants.
    Simões EAF; Chirikov V; Botteman M; Kwon Y; Kuznik A
    J Infect Dis; 2020 Mar; 221(8):1256-1270. PubMed ID: 31165865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inpatient burden of respiratory syncytial virus in children ≤2 years of age in Germany: A retrospective analysis of nationwide hospitalization data, 2019-2022.
    Wick M; Poshtiban A; Kramer R; Bangert M; Lange M; Wetzke M; Damm O
    Influenza Other Respir Viruses; 2023 Nov; 17(11):e13211. PubMed ID: 38019702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The association between climate, geography and respiratory syncitial virus hospitalizations among children in Ontario, Canada: a population-based study.
    Radhakrishnan D; Ouedraogo A; Shariff SZ; McNally JD; Benchimol EI; Clemens KK
    BMC Infect Dis; 2020 Feb; 20(1):157. PubMed ID: 32075581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Retrospective Cohort Study on Infant Respiratory Tract Infection Hospitalizations and Recurrent Wheeze and Asthma Risk: Impact of Respiratory Syncytial Virus.
    van Wijhe M; Johannesen CK; Simonsen L; Jørgensen IM; ; Fischer TK
    J Infect Dis; 2022 Aug; 226(Suppl 1):S55-S62. PubMed ID: 35426942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk-Scoring Tool for respiratory syncytial virus prophylaxis in premature infants born at 33-35 completed weeks' gestational age in Canada.
    Paes B; Steele S; Janes M; Pinelli J
    Curr Med Res Opin; 2009 Jul; 25(7):1585-91. PubMed ID: 19469698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Healthcare resource use and economic burden attributable to respiratory syncytial virus in the United States: a claims database analysis.
    Amand C; Tong S; Kieffer A; Kyaw MH
    BMC Health Serv Res; 2018 Apr; 18(1):294. PubMed ID: 29678177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimated Cardiorespiratory Hospitalizations Attributable to Influenza and Respiratory Syncytial Virus Among Long-term Care Facility Residents.
    Bosco E; van Aalst R; McConeghy KW; Silva J; Moyo P; Eliot MN; Chit A; Gravenstein S; Zullo AR
    JAMA Netw Open; 2021 Jun; 4(6):e2111806. PubMed ID: 34106266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estimates of hospitalization attributable to influenza and RSV in the US during 1997-2009, by age and risk status.
    Matias G; Taylor R; Haguinet F; Schuck-Paim C; Lustig R; Shinde V
    BMC Public Health; 2017 Mar; 17(1):271. PubMed ID: 28320361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Respiratory Syncytial Virus Infection Among Hospitalized Infants in Four Middle-Income Countries.
    Biggs HM; Simões EAF; Abu Khader I; Thompson MG; Gordon A; Hunt DR; DeGroote NP; Porter RM; Bino S; Marar BI; Gresh L; de Jesus-Cornejo J; Langley G; Thornburg NJ; Peret TCT; Whitaker B; Zhang Y; Wang L; Patel MC; McMorrow M; Campbell W; Hasibra I; Duka E; Al-Gazo M; Kubale J; Sanchez F; Lucero MG; Tallo VL; Azziz-Baumgartner E; Simaku A; Gerber SI;
    J Pediatric Infect Dis Soc; 2023 Jul; 12(7):394-405. PubMed ID: 37313727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysis.
    Li Y; Wang X; Blau DM; Caballero MT; Feikin DR; Gill CJ; Madhi SA; Omer SB; Simões EAF; Campbell H; Pariente AB; Bardach D; Bassat Q; Casalegno JS; Chakhunashvili G; Crawford N; Danilenko D; Do LAH; Echavarria M; Gentile A; Gordon A; Heikkinen T; Huang QS; Jullien S; Krishnan A; Lopez EL; Markić J; Mira-Iglesias A; Moore HC; Moyes J; Mwananyanda L; Nokes DJ; Noordeen F; Obodai E; Palani N; Romero C; Salimi V; Satav A; Seo E; Shchomak Z; Singleton R; Stolyarov K; Stoszek SK; von Gottberg A; Wurzel D; Yoshida LM; Yung CF; Zar HJ; ; Nair H;
    Lancet; 2022 May; 399(10340):2047-2064. PubMed ID: 35598608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leveraging Influenza Virus Surveillance From 2012 to 2015 to Characterize the Burden of Respiratory Syncytial Virus Disease in Canadian Adults ≥50 Years of Age Hospitalized With Acute Respiratory Illness.
    ElSherif M; Andrew MK; Ye L; Ambrose A; Boivin G; Bowie W; David MP; Gruselle O; Halperin SA; Hatchette TF; Johnstone J; Katz K; Langley JM; Loeb M; MacKinnon-Cameron D; McCarthy A; McElhaney JE; McGeer A; Poirier A; Pirçon JY; Powis J; Richardson D; Semret M; Smith S; Smyth D; Trottier S; Valiquette L; Webster D; McNeil SA; LeBlanc JJ;
    Open Forum Infect Dis; 2023 Jul; 10(7):ofad315. PubMed ID: 37441353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.